Quethera
Babraham
About Quethera
Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. Our initial focus is on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. Quethera is working alongside world leaders in the glaucoma field to design clinical trials capable of examining the efficacy and safety of novel therapies in patients who lose parts of their visual field at an accelerated rate (fast-progressors). The company has expertise in gene therapeutic design and development sufficient to progress its pipeline through preclinical testing and into clinical development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Convertible Note (Mar 2018)
- Website: quethera.co.uk
- Phone: +44 (0) 1223 804059
Industries & Categories
Biopharma, Biotechnology, Genetics, Pharmaceutical
Canonical: https://fsome.com/organization/quethera-1936203 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.